InsidersTradesSigma
亚虹医药: directors' dealings · France · AMF
SSE:688176FR·AMFMcap 6.6Bn€
Explore the full directors' dealings record of 亚虹医药, a listed issuer based in France. Shares are quoted on FR FR, under the authority of AMF. Market capitalisation: €6.6bn. The latest transaction was disclosed on 6 March 2026 — Sale. Among the most active insiders: PAN KE. Every trade is openly available.
7
Insider Decl.
0
Thresholds
·
4 ops.
Buy Volume
·
3 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
12.56 €
Income statement
Revenue277.1 M€
Gross profit205.2 M€74% margin
Net income−416.4 M€-150.3% margin
Balance sheet & cash
Market cap6.57 Bn€
Total debt345.1 M€
Free Cash Flow−430.9 M€
Last declaration on 6 March 2026
Declarations7 total
7 of 7 declarations